367 related articles for article (PubMed ID: 33962751)
21. Reorganisation of the dendritic actin network during cancer cell migration and invasion.
Vignjevic D; Montagnac G
Semin Cancer Biol; 2008 Feb; 18(1):12-22. PubMed ID: 17928234
[TBL] [Abstract][Full Text] [Related]
22. Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.
Kelley LC; Shahab S; Weed SA
Clin Exp Metastasis; 2008; 25(4):289-304. PubMed ID: 18324357
[TBL] [Abstract][Full Text] [Related]
23. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
[TBL] [Abstract][Full Text] [Related]
24. Force balancing ACT-IN the tumor microenvironment: Cytoskeletal modifications in cancer and stromal cells to promote malignancy.
Dawson MR; Xuan B; Hsu J; Ghosh D
Int Rev Cell Mol Biol; 2021; 360():1-31. PubMed ID: 33962748
[TBL] [Abstract][Full Text] [Related]
25. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
26. Nucleating actin for invasion.
Nürnberg A; Kitzing T; Grosse R
Nat Rev Cancer; 2011 Mar; 11(3):177-87. PubMed ID: 21326322
[TBL] [Abstract][Full Text] [Related]
27. Cell motility and cytoskeletal regulation in invasion and metastasis.
Kedrin D; van Rheenen J; Hernandez L; Condeelis J; Segall JE
J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):143-52. PubMed ID: 17557195
[TBL] [Abstract][Full Text] [Related]
28. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics.
Kpetemey M; Chaudhary P; Van Treuren T; Vishwanatha JK
Oncotarget; 2016 Aug; 7(34):54913-54924. PubMed ID: 27462783
[TBL] [Abstract][Full Text] [Related]
29. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
[TBL] [Abstract][Full Text] [Related]
30. Membrane tension and cytoskeleton organization in cell motility.
Sens P; Plastino J
J Phys Condens Matter; 2015 Jul; 27(27):273103. PubMed ID: 26061624
[TBL] [Abstract][Full Text] [Related]
31. Autophagy in cancer metastasis.
Mowers EE; Sharifi MN; Macleod KF
Oncogene; 2017 Mar; 36(12):1619-1630. PubMed ID: 27593926
[TBL] [Abstract][Full Text] [Related]
32. Actin as a Target to Reduce Cell Invasiveness in Initial Stages of Metastasis.
Alvarez-Elizondo MB; Merkher Y; Shleifer G; Gashri C; Weihs D
Ann Biomed Eng; 2021 May; 49(5):1342-1352. PubMed ID: 33145677
[TBL] [Abstract][Full Text] [Related]
33. WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels.
Salvi A; Thanabalu T
Biochem Biophys Res Commun; 2017 Jan; 482(4):1353-1359. PubMed ID: 27939884
[TBL] [Abstract][Full Text] [Related]
34. X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton.
Liu J; Zhang D; Luo W; Yu Y; Yu J; Li J; Zhang X; Zhang B; Chen J; Wu XR; Rosas-Acosta G; Huang C
J Biol Chem; 2011 May; 286(18):15630-40. PubMed ID: 21402697
[TBL] [Abstract][Full Text] [Related]
35. The EMT universe: space between cancer cell dissemination and metastasis initiation.
Ombrato L; Malanchi I
Crit Rev Oncog; 2014; 19(5):349-61. PubMed ID: 25404150
[TBL] [Abstract][Full Text] [Related]
36. The actin cytoskeleton as a therapeutic target: state of the art and future directions.
Giganti A; Friederich E
Prog Cell Cycle Res; 2003; 5():511-25. PubMed ID: 14593746
[TBL] [Abstract][Full Text] [Related]
37. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton.
Jiang P; Enomoto A; Takahashi M
Cancer Lett; 2009 Nov; 284(2):122-30. PubMed ID: 19303207
[TBL] [Abstract][Full Text] [Related]
38. Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process.
Bernal SD; Stahel RA
Crit Rev Oncol Hematol; 1985; 3(3):191-204. PubMed ID: 2412718
[TBL] [Abstract][Full Text] [Related]
39. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression.
Le Bras GF; Taubenslag KJ; Andl CD
Cell Adh Migr; 2012; 6(4):365-73. PubMed ID: 22796940
[TBL] [Abstract][Full Text] [Related]
40. [Effects of Rho proteins on the cytoskeleton activity and the growth regulation in tumor cells].
Shao J; Wang H; Yang L; Deng X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1462-5. PubMed ID: 19166232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
